Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Carl Zeiss Meditec Taps New CEO
Jan 2010
JENA, Germany & DUBLIN, Calif., Jan. 19, 2010 – Carl Zeiss Meditec AG has announced that Dr. Ludwin Monz, 46, will become the chief executive officer, effective after the Annual General Meeting (AGM) on March 4, 2010.

Monz will succeed Dr. Michael Kaschke, 52, who assumed the position of CEO in July 2008. Kaschke intends to return as chairman to the Supervisory Board and will stand for election at the AGM.

Monz has been a member of the Management Board of Carl Zeiss Meditec since Oct. 2007, and according to the company, has been responsible for the largest strategic business unit, Ophthalmic Systems. Previous to this, he directed the strategic business unit Microsurgery for six years. Monz joined the Carl Zeiss Group in 1994 and has been engaged in medical technology since 2000.

The company also announced that Dr. Ralf Kuschnereit was named president and CEO of the Dublin, Calif.-based US subsidiary, effective Jan. 18, 2010, as well as the appointment of Joseph Donahoe as president of Sales Americas.

The other members of the Management Board of Carl Zeiss Meditec are Dr. Christian Müller and Ulrich Krauss.

For more information, visit:

AmericaBiophotonicsBusinessCaliforniaCarl Zeiss MeditecChristian MüllerEmploymentGermanyJoseph DonahoeLudwin MonzMichael Kaschkemicrosurgeryophthalmic systemsRalf KuschnereitUlrich Krauss

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.